返回 Agendas
Best Practices for Effective Engagement with Patient Groups Around Clinical Trials
Session Chair(s)
Bray Patrick-Lake, MS
Senior Digital Health Specialist, DDH, CDRH
FDA, United States
This forum will review evidence from Clinical Trials Transformation Initiative's Patient Groups & Clinical Trials project literature search, joint survey with DIA, and key informant interviews on practices that support effective partnerships. Value and associated metrics will also be examined.
Learning Objective : Define current research sponsor practices for engaging with patient groups; Describe barriers and successes that have led to more effective partnerships around clinical trials; Identify what patient groups, research sponsors, and investigators are hoping to achieve through partnerships around clinical trials; Discuss how they measure success and value.
Speaker(s)
CTTI Patient Groups and Clinical Trials Project: Key Findings
Wendy Selig, MS
WSCollaborative, United States
Founder and Chief Executive Officer
What Industry Is Measuring Around Patient Group Partnerships
David P. Leventhal, MBA
Pfizer Inc, United States
Enterprise Clinical Trial Data Sharing Lead, Global Data Dissemination
Patient Groups and Clinical Trials: Concepts of Value
Matthew Harker, MBA, MPH
Clinical Trials Transformation Initiative (CTTI), United States
Director, CHLC
Panelist
Petra Kaufmann, MD, MSc
National Center for Advancing Translational Sciences, NIH, United States
Director, Office of Rare Diseases and Divison of Clinical Innovation